Evolution of the Average Target: UBS Group AG

Evolution of the Target Price: UBS Group AG

Changes in Analyst Recommendations: UBS Group AG

466f07e6990d77c6.71zzAmQT3HsiVWOW4eNB_KgiVmdNMb6_36ecbNpN6ws.qDm3dwdBizpWLDbAsIxwmutoMC8GYeTOqpPlQY4uoDmtGZZJNVyUVnZsUw~08445863bbebc3a8ab4308fea01075f3
07-15 Visa's Remaining Performance Obligations Provide Revenue Growth Visibility, UBS Says MT
07-13 Mattel's Brand Equity Worth Far More Than Market Implies, UBS Says MT
07-09 UBS AG : Gets a Buy rating from RBC ZD
07-08 Lufthansa in a rough patch, analysts grow concerned Zonebourse
07-06 Helen of Troy to Keep Fiscal 2027 Outlook as Sales Trends Improve, UBS Says MT
07-06 UBS in the green on BofA comments Zonebourse
07-06 BofA Sees Strong EPS Momentum for UBS Group in Q2; Price Objective, Forecasts Raised MT
07-06 UBS AG : Buy rating from JP Morgan ZD
07-02 'Absolutely No Sign' of Let Up in AI Demand, UBS Says MT
06-29 Swiss Stocks Open Week Upbeat; Sandoz Group Gains MT
06-29 UBS AG : Receives a Buy rating from Deutsche Bank ZD
06-26 WINNERS & LOSERS: British American Tobacco announces buyback AN
06-25 UBS AG : Buy rating from Jefferies ZD
06-23 Apogee Therapeutics' Acquisition by AbbVie Fairly Values Zumilokibart, UBS Says MT
06-22 Barclays Keeps UBS Group at Equalweight, Boosts PT MT
06-22 UBS AG : Barclays reaffirms its Neutral rating ZD
06-19 Keefe, Bruyette & Woods Downgrades UBS Group to Underperform, Lifts PT MT
06-19 KBW Downgrades Weigh on UBS and Julius Bär Zonebourse
06-18 UBS AG : Gets a Buy rating from Jefferies ZD
06-16 Redcare Pharmacy Surprises with Strong Performance and Raises Guidance Zonebourse
06-09 Australia's REA Group falls after UBS downgrade on volume risks from tax changes RE
06-09 UBS, Givaudan Drive Swiss Shares Higher as Middle East Tensions Ease MT
05-27 China, HK shares end lower as AI, property offset strong profit data RE
05-26 Tech Up as Micron Leads Chip Surge - Tech Roundup DJ
05-26 UBS AG : RBC reaffirms its Buy rating ZD

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
-0.93%
+22.51%
+5.4%
+27.5%
+18.24%
+7.89%
+4.43%
+30.13%
-2.89%
-6.19%
Average +10.61%
Weighted average by Cap. +12.02%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
42.54CHF
Average target price
42.15CHF
Spread / Average Target
-0.93%
High Price Target
60.00CHF
Spread / Highest target
+41.04%
Low Price Target
33.99CHF
Spread / Lowest Target
-20.10%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

RBC Anke Reingen
JPMORGAN Kian Abouhossein
JEFFERIES Joseph Dickerson
Barclays
Keefe, Bruyette & Woods
GOLDMAN SACHS Chris Hallam
DZ BANK Philipp Dr. Häßler
alphavalue Quentin de Villeneuve
RBC Capital Markets
BNP Paribas
DEUTSCHE BANK RESEARCH Benjamin Goy
Morgan Stanley
ODDO BHF
Keefe Bruyette
Kepler Cheuvreux
BERENBERG Peter Richardson
Citigroup
Axiom Capital Management
BofA Securities
CREDIT SUISSE Jon Peace
BNP Paribas Exane
Exane BNP Paribas
DEUTSCHE BANK Benjamin Goy
Auriga
Jefferies & Co.
Deutsche Bank Securities
HSBC Piers Brown
BANK OF AMERICA (BOFA) Andrew Stimpson
BAADER BANK Tomasz Grzelak
MERRILL LYNCH Andrew Stimpson
Trader
Investor
-
Global
-
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
42.54CHF
Average target price
42.15CHF
Spread / Average Target
-0.93%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. UBSG Stock
  4. Consensus UBS Group AG